Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial

Abstract

Outcome instruments

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (42)

• Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
• Aromatase expression in endometriosis via openalex
• Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings via openalex
• Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? via openalex
• Aromatase inhibitors for the treatment of endometriosis via openalex
• Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
• Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside via openalex
• Committee Opinion No. 663: Aromatase Inhibitors in Gynecologic Practice via openalex
• Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
• Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol via openalex
• Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis via openalex
• Full-Thickness Excision versus Shaving by Laparoscopy for Intestinal Deep Infiltrating Endometriosis: Rationale and Potential Treatment Options via openalex
• GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis via openalex
• Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression via openalex
• Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis via openalex
• Letrozole and norethisterone acetate in colorectal endometriosis via openalex
• Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial via openalex
• Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach via openalex
• Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial via openalex
• Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study via openalex
• Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex
• Progesterone Resistance in Endometriosis: an Acquired Property? via openalex
• Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
• Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
• Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
• The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
• The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence via openalex
• The emerging use of aromatase inhibitors for endometriosis treatment via openalex
• The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex
• The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis via openalex
• The pathophysiology of endometriosis and adenomyosis: tissue injury and repair via openalex
• Treatment of endometriosis with transvaginal ultrasound-guided drainage and recombinant interleukin-2 left in the cysts: a third clinical trial via openalex
• Treatment of endometriosis with transvaginal ultrasound-guided drainage under GnRH analogues and recombinant interleukin-2 left in the cysts via openalex
• Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex

Source provenance

openalex

last seen: 2026-05-13T18:33:16.088889+00:00